scholarly journals Gender and immunosuppression impact on Merkel cell carcinoma diagnosis and prognosis. A population based cohort study

2021 ◽  
Author(s):  
E. Keeling ◽  
E. O'Leary ◽  
S. Deady ◽  
J. P. O Neill ◽  
P. J. Conlon ◽  
...  

2017 ◽  
Vol 76 (3) ◽  
pp. 570-572 ◽  
Author(s):  
Maressa C. Criscito ◽  
Kathryn J. Martires ◽  
Jennifer A. Stein


2019 ◽  
Vol 81 (4) ◽  
pp. 977-983 ◽  
Author(s):  
Sanne E. Uitentuis ◽  
Marieke W.J. Louwman ◽  
Alexander C.J. van Akkooi ◽  
Marcel W. Bekkenk


2017 ◽  
Vol 76 (1) ◽  
pp. 166-167 ◽  
Author(s):  
Reshmi Madankumar ◽  
Maressa C. Criscito ◽  
Kathryn J. Martires ◽  
Jennifer A. Stein




Author(s):  
Kurian Joseph ◽  
Justina Wong ◽  
Aswin Abraham ◽  
Julia Zebak ◽  
Anushree Patel ◽  
...  


2011 ◽  
Vol 165 (5) ◽  
pp. 1051-1057 ◽  
Author(s):  
J. Girschik ◽  
K. Thorn ◽  
T.W. Beer ◽  
P.J. Heenan ◽  
L. Fritschi


2018 ◽  
Vol 144 (4) ◽  
pp. 741-745 ◽  
Author(s):  
Alice Kieny ◽  
Bernard Cribier ◽  
Nicolas Meyer ◽  
Michel Velten ◽  
Jérémie Jégu ◽  
...  


2014 ◽  
Vol 2014 ◽  
pp. 1-7 ◽  
Author(s):  
Anshul Saxena ◽  
Muni Rubens ◽  
Venkataraghavan Ramamoorthy ◽  
Hafiz Khan

The risk of second cancers in Merkel cell carcinoma (MCC) remains uncertain since risk estimates vary worldwide. The global MCC population is growing and there is a demand for better knowledge of prognosis of this disease. The Cochrane Database of Systematic Reviews, MEDLINE, and EMBASE search engines were searched for the relevant literature between January 1999 and September 2014 by use of explicit search criteria. The main outcome was second malignancies associated with MCC patients measured by standardized incidence ratios (SIRs) or other estimates of risks. Five papers fulfilled the inclusion criteria and reported SIRs of second cancer in MCC which varied from 1.07 to 2.80. Performing meta-analysis using random effects model revealed that there was an increased risk for second malignancies due to MCC (SIR, 1.52; 95% CI, 1.10–2.11). There was a significant increase in risk for malignant melanoma (SIR, 3.09; 95% CI, 2.02–4.73) as compared to all common second malignancies among the studies. Updated knowledge about risk of second malignancies in MCC will help in better assessment of the disease prognosis and will help in optimizing the medical and surgical treatment, radiotherapy, follow-up, and surveillance procedures.



2015 ◽  
Vol 173 (3) ◽  
pp. 835-837 ◽  
Author(s):  
J.P. Robertson ◽  
E.S. Liang ◽  
R.C.W. Martin


2012 ◽  
Vol 18 (10) ◽  
pp. 2872-2881 ◽  
Author(s):  
Harri Sihto ◽  
Tom Böhling ◽  
Heli Kavola ◽  
Virve Koljonen ◽  
Marko Salmi ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document